US Patent 8945560 Method of treating rheumatoid arthritis using antibody to IL6R

Patent 8945560 was granted and assigned to Kymab on February, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Kymab

Current Assignee

Kymab

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8945560

Date of Patent

February 3, 2015

Patent Application Number

14457566

Date Filed

August 12, 2014

Patent Citations Received

‌

US Patent 11673967 Stabilized formulations containing anti-PCSK9 antibodies

‌

US Patent 11904017 Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab

Patent Primary Examiner

‌

Sharon Wen

Patent abstract

The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8945560 Method of treating rheumatoid arthritis using antibody to IL6R

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API